Trevi Therapeutics (TRVI)
(Delayed Data from NSDQ)
$2.84 USD
+0.15 (5.59%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $2.88 +0.05 (1.59%) 5:58 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.09 | 2.86% |
Earnings Summary
For their last quarter, Trevi Therapeutics (TRVI) reported earnings of -$0.08 per share, beating the Zacks Consensus Estimate of $-0.10 per share. This reflects a positive earnings surprise of 20.00%. Look out for TRVI's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for TRVI
Why Trevi Therapeutics (TRVI) Stock Might be a Great Pick
TRVI: What are Zacks experts saying now?
Zacks Private Portfolio Services